Meta Found Liable in New Mexico Facebook Data Privacy Case 
US Stock Futures Fall as Treasury Yields Surge Ahead of Trump-Xi Summit 
BMW 2028 Margin Target Could Fall Below Consensus, UBS Says 
Solidigm Eyes $150 Billion IPO as SK Hynix Expands AI Storage Push 
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal 
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears 
SMBC Eyes 20% VPBank Stake in Vietnam Expansion 
Dubai’s connectivity remains strong in an uncertain world 
Australia Unemployment Hits Five-Year High Despite Strong Jobs Growth 
Canadian Dollar Faces Pressure as Fed-BoC Policy Gap Widens 
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue 
Tesla Semi Rollout Begins at Nevada Factory 
Japan Private-Sector Growth Slows as Domestic Demand Weakens 
Apple Extends Qualcomm Patent Licensing Deal 
China’s ‘Lipstick King’ Says AI Won’t Replace Livestream Hosts 
Dollar Holds Near Two-Month High as Yen Approaches 160 
Suzuki Targets Faster Car Development to Keep Pace With Chinese Rivals 
Add as a preferred source on Google
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
